DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lip GY, Keshishian A, Kamble S. et al.
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin.
Thromb Haemost 2016;
116: 975-986.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.